Salvage Chemotherapy with Taxol for Recurrent Anaplastic Astrocytomas

Abstract
Background: A prospective Phase II study of Taxol in young adult patients with recurrent anaplastic astrocytomas. Methods: Twenty-four patients (15 men; 9 women) ages 19–45 years (median 31.5), with...